SNDL (SNDL) Stock Price, News & Analysis

Company Overview

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

Key Stats

• Today's Range: $1.62 to $1.71
• 50-Day Range: $1.21 to $1.72
• 52-Week Range: $1.15 to $2.40
• Volume: 4.38 million shs
• Average Volume: 2.85 million shs
• Market Capitalization: $433.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: N/A

SNDL Stock Analysis - MarketRank™

SNDL scored higher than 52% of companies evaluated by MarketBeat, and ranked 482nd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: N/A

Amount of Analyst Coverage

SNDL has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for SNDL are expected to grow in the coming year, from ($0.09) to ($0.01) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of SNDL is -6.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of SNDL is -6.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

SNDL has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.12% of the float of SNDL has been sold short.

Short Interest Ratio / Days to Cover

SNDL has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SNDL has recently decreased by 7.17%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SNDL does not currently pay a dividend.

Dividend Growth

SNDL does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.12% of the float of SNDL has been sold short.

Short Interest Ratio / Days to Cover

SNDL has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SNDL has recently decreased by 7.17%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.86

News Sentiment

SNDL has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for SNDL this week, compared to 2 articles on an average week.

Search Interest

Only 8 people have searched for SNDL on MarketBeat in the last 30 days. This is a decrease of -11% compared to the previous 30 days.

MarketBeat Follows

6 people have added SNDL to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SNDL insiders have not sold or bought any company stock.

SNDL Stock Analysis - Frequently Asked Questions

How have SNDL shares performed this year?

SNDL's stock was trading at $1.79 at the start of the year. Since then, SNDL stock has decreased by 7.8% and is now trading at $1.65.

How were SNDL's earnings last quarter?

SNDL Inc. (NASDAQ:SNDL) announced its earnings results on Thursday, July, 31st. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.04) by $0.05. The company had revenue of $179.78 million for the quarter, compared to analyst estimates of $231.50 million. SNDL had a negative trailing twelve-month return on equity of 8.47% and a negative net margin of 10.38%.
Read the conference call transcript.

When did SNDL's stock split?

SNDL shares reverse split before market open on Tuesday, July 26th 2022.The 1-10 reverse split was announced on Tuesday, July 26th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

When did SNDL IPO?

SNDL (SNDL) raised $130 million in an initial public offering (IPO) on Thursday, August 1st 2019. The company issued 10,000,000 shares at $12.00-$14.00 per share. Cowen, BMO Capital Markets and Barclays acted as the underwriters for the IPO.

Who are SNDL's major shareholders?

SNDL's top institutional investors include Magnus Financial Group LLC (0.06%) and R Squared Ltd (0.05%).

How do I buy shares of SNDL?

Shares of SNDL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SNDL own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SNDL investors own include Zomedica (ZOM), AMC Entertainment (AMC), NIO (NIO), Meta Platforms (META), Tesla (TSLA), Jumia Technologies (JMIA) and

Company Calendar

• Last Earnings: 7/31/2025
• Today: 8/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SNDL
• CIK: 1766600
• Web: www.sundialcannabis.com
• Phone: (844) 249-6746
• Fax: N/A
• Employees: 2,516
• Year Founded: N/A

Price Target and Rating

• Average Price Target for SNDL: $4.00
• High Price Target: $4.00
• Low Price Target: $4.00
• Potential Upside/Downside: +142.4%
• Consensus Rating: N/A
• Rating Score (0-4): 0.00
• Research Coverage: 0 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$69.18 million
• Net Margins: -10.38%
• Pretax Margin: -12.23%
• Return on Equity: -8.47%
• Return on Assets: -7.14%

Debt

• Debt-to-Equity Ratio: 0.10
• Current Ratio: 4.62
• Quick Ratio: 3.12

Sales & Book Value

• Annual Sales: $671.81 million
• Price / Sales: 0.65
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.15 per share
• Price / Book: 0.52

Miscellaneous

• Outstanding Shares: 262,780,000
• Free Float: N/A
• Market Cap: $433.59 million
• Optionable: Optionable
• Beta: 3.57